AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 251 min read$CGC

Stewart Thomas Carlton sold $3K of CGC

Stewart Thomas Carlton (See Remarks) sold 2,231 shares of Canopy Growth Corp (CGC) at $1.47 on 2026-08-24.

Original reporting
SEC EDGAR · Stewart Thomas Carlton
Published Aug 25, 2026, 9:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 9:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$CGC
Neutral
high confidence
Mentioned
$CGC
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CGCNeutralLow
01

Why it matters

The sale is minor and does not suggest material information; likely routine portfolio rebalancing.

02

Market read

Low relevance; the filing provides a new data point but lacks material impact.

03

What to watch

Potential upcoming corporate actions or financing that may prompt larger insider activity.

Relevance 3/10Novelty 4/10Timing: post-market filing on 2026-08-24

Background

Form 4 filings disclose insider trades; investors track them for signals of insider sentiment.

Company-level read

Ticker impact

$CGCNeutralHigh confidence
Context

Officer Stewart Thomas Carlton sold 2,231 shares of Canopy Growth at $1.47 each, total $3,279.57.

Expected impact

minimal impact, price likely unchanged

Evidence & confidence

The transaction size is trivial relative to market cap and typical daily volume.

Market effects

Sector

None; cannabis sector not affected by this small insider transaction.

Regional

No regional impact.

Global

Insignificant.

Counterpoint

What could challenge this read

Even small insider sales can signal lack of confidence; monitor for larger future disposals.

Key entities

  • Company
    Canopy Growth Corp

    Canadian cannabis producer listed on NYSE under CGC.

  • Officer
    Stewart Thomas Carlton

    Company officer who sold shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CGC insider trading history →

Related articles

AUG 24
$CURLFHighAI 9/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf has made an unsolicited bid for Aurora Cannabis, offering a 45% premium. Aurora has not accepted the deal. Tilray Brands and Canopy Growth are also engaging in consolidation. Aurora recently acquired Safari Flower, while Canopy bought MTL Cannabis. Tilray is diversifying into alcohol and CBD. Investors should consider risks of consolidation strategies.

aol.com3 min
AUG 21
$CURLFHighAI 8/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf (CURLF) has made an unsolicited bid for Aurora Cannabis (ACB), offering a 45% premium. Aurora's response was noncommittal. Canopy Growth (CGC) and Tilray Brands (TLRY) are also consolidating, with Tilray expanding into alcohol and CBD. Investors may benefit from acquisitions, but risks include integration challenges and leverage.

fool.com3 min
AUG 21
$CGCMedAI 8/10

Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell?

Canopy Growth Corporation (CGC) shares rose 15% in a month after reporting Q1 fiscal 2027 earnings that beat estimates, showing revenue growth and improved margins. The company's cannabis business is improving, with increased revenues and narrowing losses. However, cash flow remains a concern, and competition in the cannabis market is stiff. Analysts have slightly improved loss estimates but maintain a 'Hold' rating.

zacks.com3 min
AUG 16
$CURLFMedAI 8/10

Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target?

Curaleaf launched an unsolicited offer to buy Aurora Cannabis for $272 million, or $4 per share, about a 45% premium to Aurora’s 30-day VWAP, aiming for about $1.5 billion revenue, $350 million adjusted EBITDA, and $40 million annual cost synergies. The article also discusses whether Canopy Growth could be a future acquisition target, citing its turnaround and global medical cannabis platform.

yahoo.com4 min